Key Takeaway: Human trials confirm NMN and NR raise NAD+ levels in blood. Here is what the clinical evidence actually shows—and does not show—for men over 40.

Man in his 50s reading supplement labels at a pharmacy counter in morning light, documentary black and white photography

NAD+ levels in a typical 50-year-old man sit at roughly half the concentration measured at age 20. That single metabolic fact built a billion-dollar supplement category around one question: can you restore those levels by swallowing a capsule, and would restoring them change anything you can measure?

Multiple randomized controlled trials now settle the first part. NMN and NR, the two dominant NAD+ precursors, raise blood NAD+ in human subjects. The second part, whether those restored levels translate into health outcomes men over 40 can feel or measure, carries a more complex answer. Some trials show real improvements in muscle function, aerobic capacity, and sleep quality. Others show raised NAD+ with no metabolic benefit at all.

This review is written for men over 40 who want to understand the actual clinical evidence before spending $60 to $120 per month on NAD+ precursors. It covers what the human data supports, what it does not, and a practical protocol for men who decide the evidence warrants action.

Key Takeaways

  • NAD+ drops with age: Blood NAD+ in men at 50 averages roughly 50% of the level at age 20. By 60, the decline continues further.
  • NMN and NR both raise NAD+: Every published human trial measuring blood NAD+ has found increases within weeks of starting either compound.
  • Muscle and physical performance: A 12-week trial in men over 65 (Igarashi et al., npj Aging, 2022) found 250mg NMN improved gait speed and grip strength compared to placebo.
  • Aerobic capacity: A 6-week randomized trial in male runners (Liao et al., JISSN, 2021) found 300mg and 600mg NMN improved ventilatory threshold and oxygen efficiency.
  • Metabolic health: Results split. A Science study in women with prediabetes found improved insulin sensitivity on NMN. Three separate NR trials in men with metabolic risk found no improvement despite raising NAD+.
  • Safety: Well-tolerated in published trials at up to 1,200mg/day NMN and 2,000mg/day NR.
  • Longevity outcomes: No human data exists yet. NAD+ restoration is a mechanism, not a proven lifespan outcome.
  • Dose: Most human trials used 250mg to 500mg/day NMN or 300mg to 1,000mg/day NR.

Table of Contents

What NAD+ Does in the Body

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell. It performs two distinct functions, and age-related decline in either produces measurable harm.

The first is metabolic. NAD+ accepts electrons during the breakdown of glucose and fatty acids, then passes them to the mitochondrial electron transport chain where ATP (cellular energy) is made. When NAD+ levels fall, this chain runs at reduced capacity. Cells generate less energy per unit of fuel consumed.

The second is regulatory. NAD+ activates sirtuins, a family of seven proteins (SIRT1 through SIRT7) that govern gene expression, inflammation response, DNA repair, and fat metabolism. SIRT1 controls insulin sensitivity and fat mobilization in muscle. SIRT3 governs mitochondrial biogenesis in cardiac and skeletal muscle. SIRT6 repairs DNA breaks. These pathways sit at the center of cellular aging research.

NAD+ also powers PARP enzymes, which detect and patch DNA damage. The body accumulates DNA damage with each passing decade. PARP enzymes and sirtuins compete for the same NAD+ supply. In older men, chronic low-grade inflammation and accumulated DNA damage push that competition toward repair at the expense of energy production and sirtuin activity.

Why NAD+ Falls After 40

Three mechanisms drive the decline, and they compound each other.

Reduced synthesis. The enzyme NAMPT controls the rate-limiting step in NAD+ production in most tissues. NAMPT activity falls with age in human muscle, liver, and fat tissue. Production slows even when dietary precursors (tryptophan, niacin) are available in normal amounts.

Increased degradation. The enzyme CD38 degrades NAD+ and becomes more active with age and with chronic inflammation. Research published in Cell Metabolism (Camacho-Pereira et al., 2016) identified CD38 as a primary driver of the NAD+ decline seen in aging and found correlations between CD38 activity and NAD+ loss in human tissue samples. Visceral fat tissue, which accumulates in men after 40, expresses high levels of CD38.

Repair demand. More accumulated DNA damage means PARP enzymes consume more NAD+ for repair work. This draws from the same pool sirt enzymes need. The result is a self-reinforcing cycle: lower NAD+ means slower SIRT-mediated repair, which means more damage, which means more PARP demand, which means lower NAD+.

By 50, most men have roughly half the NAD+ of their 20-year-old baseline. The practical effects span energy, body composition, and inflammatory load across multiple systems.

NMN vs NR: The Two Precursors

NAD+ itself cannot be usefully supplemented because it does not cross cell membranes. The standard approach uses precursor molecules that enter cells and convert to NAD+ internally. Two compounds dominate the market and the clinical literature.

NR (nicotinamide riboside): Cells convert NR to NMN, then NMN to NAD+. NR has the longer research history. The first human trial (Trammell et al., Nature Communications, 2016) established its bioavailability and showed a single dose raised blood NAD+ within hours. Most published human trials on NAD+ precursors in older adults use NR.

NMN (nicotinamide mononucleotide): One biosynthetic step closer to NAD+. Research from Washington University identified a specific NMN transporter in mouse gut cells (Slc12a8), suggesting NMN may enter cells through a dedicated channel rather than requiring conversion to NR first. Whether this transporter exists in human gut cells and whether it confers a meaningful advantage remains an open research question.

In practice, both compounds produce the same endpoint in published human trials: increased blood NAD+. No direct head-to-head comparison at matched doses exists in humans. Most researchers treat them as functionally equivalent options rather than superior versus inferior compounds.

Cost is a practical differentiator. High-quality NMN runs $60 to $120 per month at 500mg/day doses. High-quality NR runs $30 to $60 per month for doses producing similar NAD+ elevations.

What Human Trials Show

Safety and NAD+ Elevation

The first published human NMN safety trial (Irie et al., Endocrinology Journal, 2020) enrolled 10 healthy men and administered 500mg oral NMN. The study found no adverse clinical effects and confirmed the compound absorbed and metabolized without harm.

A larger randomized controlled trial (GeroScience, Yi et al., 2023) enrolled healthy middle-aged adults at three NMN doses: 300mg, 600mg, and 900mg daily for 60 days. All three groups showed elevated blood NAD+ compared to placebo in a dose-dependent pattern. No serious adverse events occurred across any dose group.

NR produces parallel findings. Trammell et al. (2016) found a single NR dose raised blood NAD+ by 60% within eight hours. Martens et al. (Nature Communications, 2018) showed 1,000mg NR daily for six weeks sustained a 60% increase in NAD+ in adults aged 55 to 79, with no adverse events.

The summary: both compounds raise blood NAD+ in every published human trial that has measured it. Safety at doses used in clinical research is established.

Muscle Function and Physical Performance

The most male-specific trial published to date appears in npj Aging (Igarashi et al., 2022). Thirty men aged 65 and older received 250mg NMN daily for 12 weeks. Compared to the placebo group, NMN supplementation improved gait speed and grip strength, two markers that predict fall risk and all-cause mortality in older men. The improvements were modest in absolute terms but statistically meaningful in a population where muscle decline directly predicts clinical outcomes.

For men who want to understand where aerobic capacity fits into the same longevity framework, our VO2 max training guide for men over 40 covers the mortality data in detail.

A separate randomized trial (Journal of the International Society of Sports Nutrition, Liao et al., 2021) enrolled 48 recreational male runners and gave them 300mg or 600mg NMN daily for six weeks. Both NMN groups improved ventilatory threshold and oxygen efficiency compared to placebo, suggesting improved aerobic capacity at a cellular level. Absolute VO2 max differences were small, but the direction was consistent across both dose groups.

Metabolic Health

This section contains the most contested data in the NMN literature.

The most cited metabolic trial (Science, Yoshino et al., 2021) administered 300mg NMN to 25 postmenopausal women with prediabetes for 10 weeks. The NMN group showed improved insulin sensitivity in skeletal muscle, with gene expression changes consistent with muscle remodeling. This was the first human evidence of a downstream functional metabolic effect.

The NR trials in men with metabolic risk factors tell a different story. Dollerup et al. (American Journal of Clinical Nutrition, 2018) gave obese men 2,000mg NR daily for 12 weeks. Blood NAD+ rose substantially. Insulin sensitivity did not improve. Remie et al. (2020) gave overweight men 1,000mg NR for six weeks. NAD+ metabolism increased. Metabolic markers did not change.

The discrepancy may reflect genuine differences between NMN and NR, between prediabetic women and obese men, or between different disease stages. No trial has directly compared NMN and NR in matched male populations with metabolic risk. Men with existing metabolic syndrome should not expect automatic improvement from NAD+ precursors based on current evidence.

Cardiovascular Markers

Martens et al. (2018) found 1,000mg NR for six weeks produced a modest 3 mmHg reduction in systolic blood pressure and reduced aortic stiffness in healthy adults over 55. These are intermediate markers rather than clinical outcome data, and the effect size is small. The direction is consistent with NAD+'s role in vascular smooth muscle regulation.

Combining NMN or NR with regular sauna sessions targets vascular health through separate mechanisms, including heat shock protein upregulation and plasma volume expansion, which may produce additive effects. No trial has examined the combination.

Sleep and Cognitive Function

A randomized trial (Translational Psychiatry, Kim et al., 2022) administered NMN to middle-aged and older adults for 12 weeks and measured self-reported sleep quality, eye fatigue, and neuroimaging markers. The NMN group reported improved sleep quality and reduced eye fatigue. Neuroimaging showed structural changes in the NMN group that differed from placebo. The study was small and preliminary, with subjective sleep quality as a primary outcome. The findings are interesting and warrant replication in larger trials.

What the Evidence Does Not Show

No human trial has demonstrated that NMN or NR extends lifespan, reduces cancer incidence, reverses cardiovascular disease, or prevents dementia. The longevity data comes from animal models, primarily mice and yeast. Rodent NAD+ metabolism differs from human metabolism in specific ways, and results that appeared in mice have failed to translate to humans across multiple other research areas.

The mechanistic case for why higher NAD+ would slow human aging is plausible. Sirtuins regulate processes central to cellular aging. PARP activity governs genomic stability. Mitochondrial function declines with age partly through NAD+ depletion. Restoring NAD+ addresses each of these at the cellular level.

Plausible mechanisms and proven clinical outcomes are different things. Men considering NMN or NR should understand they are acting on a strong mechanistic hypothesis backed by early human data, not on proven longevity outcomes.

This is why the foundation of longevity strategy for men over 40 remains exercise, sleep, and nutrition. The 15 longevity habits with the most consistent human evidence are behavioral, not pharmacological. NMN and NR sit on top of that foundation, not in place of it. The full review of evidence-based anti-aging supplements covers omega-3, vitamin D, magnesium, creatine, and berberine, all of which have larger or longer human trial datasets than NMN.

Dosage and Timing Protocol

NMN

Most published human trials used 250mg to 500mg daily. The safety trial confirmed 500mg as well-tolerated in men. The GeroScience RCT confirmed 300mg, 600mg, and 900mg all raised NAD+ without adverse events.

Harvard professor David Sinclair has reported taking 1,000mg NMN daily and has written about it extensively in the longevity research community. No large-scale trial has validated this specific dose in men over 40 against clinical outcomes, though the safety data at that dose suggests low risk.

A practical starting protocol: 300mg to 500mg with morning food for 8 to 12 weeks, then assess whether any subjective or measurable changes occur (energy, exercise capacity, sleep). Some manufacturers offer sublingual NMN formats claiming improved absorption by bypassing first-pass gut metabolism. Human pharmacokinetic data comparing sublingual to oral NMN at matched doses does not yet exist in sufficient quantity to recommend sublingual over high-quality oral capsules.

NR

Trials used doses ranging from 250mg to 2,000mg daily. The 300mg dose in Trammell et al. raised blood NAD+ substantially. The cardiovascular marker improvements in older adults used 1,000mg.

A practical starting dose: 300mg to 500mg daily with food, consistent with doses that produced NAD+ elevation in most trials without the cost burden of higher doses.

Cycling

Some practitioners recommend cycling four weeks on and one week off, on the theory that sustained supplementation may trigger compensatory downregulation. No human trial has compared cycled versus continuous NAD+ precursor supplementation. Cycling is based on inference from other supplement categories, not NMN or NR data.

How to Evaluate Product Quality

NMN is expensive to manufacture at high purity. The quality gap between brands is substantial.

Third-party testing: Look for a Certificate of Analysis from an independent laboratory, not the manufacturer's internal quality testing. The COA should show high-performance liquid chromatography (HPLC) purity data above 99% and test for heavy metals and microbial contamination.

Stability: NMN degrades with heat and light exposure. Powder sold in clear containers should raise concern. Quality brands use dark glass or opaque containers and specify refrigeration after opening or at minimum cool-dry storage.

Form: Oral capsules and powder are both appropriate starting formats. Sublingual drops and tablets are marketed as superior for bioavailability but lack comparison data against oral forms in humans. Liposomal NMN is another format with limited clinical testing.

For NR specifically: The form used in the majority of clinical trials is nicotinamide riboside chloride, not free-base NR. Verify which form the product uses.

Third-party certifications: NSF International, Informed Sport, or USP verification add an additional layer of manufacturing quality assurance, particularly relevant given that no NMN brand has FDA approval (NMN is a dietary supplement, not a drug).

Who Should Consider NMN or NR

NMN or NR makes sense for men who:

  • Are 45 or older and have moved beyond the basics of exercise, sleep, and protein intake
  • Have the budget for three or more months of consistent supplementation to assess individual response ($60 to $120/month for quality NMN)
  • Understand the distinction between NAD+ restoration (confirmed in human trials) and longevity outcomes (not yet confirmed in human trials)
  • Want to address muscle or aerobic capacity alongside training, given the modest improvements seen in the Igarashi and Liao trials

Skip it if:

  • Diet, sleep, and regular strength training are not already in place. No NMN trial has shown benefits that override deficits in these areas.
  • You are looking for a metabolic fix. The NR trials in obese or overweight men found no insulin sensitivity improvements, and the metabolic data is not strong enough in men to rely on for that goal.
  • Cost forces a choice between NMN and other supplements with stronger human evidence. Omega-3, vitamin D, and creatine each have larger outcome datasets and cost a fraction of NMN at equivalent doses.

Before adding NAD+ precursors to your stack, get routine health screenings that include a metabolic panel. A baseline gives you something to compare against after 12 weeks of supplementation and flags contraindications your doctor needs to know about.

FAQ

What is the difference between NMN and NAD+ supplements?

NAD+ itself does not cross cell membranes, so direct NAD+ supplementation has limited effect on intracellular levels. NMN is a precursor that cells convert to NAD+ inside the cell through the salvage biosynthesis pathway. Human trials show NMN raises blood NAD+ within hours of a dose. NAD+ capsules sold as supplements are largely metabolized before reaching tissues and are not equivalent to NMN.

How long does NMN take to produce effects?

Blood NAD+ elevations appear within eight hours of a single dose in pharmacokinetic studies. The muscle function improvements in the Igarashi trial in older men appeared at 12 weeks. Men who respond to NMN supplementation should expect 8 to 12 weeks before any functional changes become measurable.

Is NMN safe for men over 40?

Published human trials have found NMN well-tolerated at doses up to 1,200mg daily. The most common side effects reported are mild gastrointestinal discomfort at higher doses. No serious adverse events appeared in any published human trial. Long-term data beyond 12 weeks is limited, and no regulatory body has reviewed NMN as a drug. Discuss with your physician before starting, particularly if you take medications that affect NAD+ metabolism or have liver disease.

Should I take NMN or NR?

Both raise blood NAD+ in every published human trial. NR has more accumulated clinical data across a longer research period. NMN may have a mechanistic advantage via the Slc12a8 gut transporter, though this has not been confirmed in humans. NR costs less. Choose based on product quality and budget rather than on mechanistic superiority claims that have not been demonstrated in head-to-head human trials.

Can I stack NMN with other supplements?

NMN combines with several compounds that work on related pathways. Apigenin, a flavonoid found in parsley and chamomile, inhibits CD38, the enzyme that degrades NAD+. Combining apigenin (100mg to 200mg) with NMN is theoretically complementary, though no human trial has tested the combination. Standard co-supplementation with omega-3, vitamin D, and magnesium is safe and does not interfere with NMN pharmacokinetics.

Does NMN affect testosterone levels?

No published clinical trial has demonstrated a direct link between NMN and testosterone levels in men. Sirtuin pathways activated by higher NAD+ influence hormone signaling across multiple axes, but a specific testosterone effect has not been isolated in human research. Men looking to address testosterone should review evidence-based options separately from the NAD+ precursor category.

Consult your healthcare provider before starting any new supplement program. This article is for educational purposes only and does not constitute medical advice. Individual responses to NMN and NR vary, and supplementation decisions should account for your current health status, medications, and specific goals.

Related reading: Anti-Aging Supplements That Actually Work for Men | 15 Longevity Habits Every Man Over 40 Should Adopt

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any new exercise, nutrition, or supplement program.